Melanoma Immunotherapy: Past, Present, and Future
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
3461-3473
Author(s):
F. Saleh, W. Renno, I. Klepacek, G. Ibrahim, S. Asfar, H. Dashti, P. Romero, A. Dashti and A. Behbehani
Decreasing the Metastatic Potential in Cancers - Targeting the Heparan Sulfate Proteoglycans
Journal:
Current Drug Targets
Volume:
6
Page:
665-682
Author(s):
K. Fjeldstad and S. O. Kolset
Isoprenylation of Intracellular Proteins as a New Target for the Therapy of Human Neoplasms: Preclinical and Clinical Implications
Journal:
Current Drug Targets
Volume:
6
Page:
301-323
Author(s):
M. Caraglia, A. Budillon, P. Tagliaferri, M. Marra, A. Abbruzzese and F. Caponigro
Targeting Cytotoxic Conjugates of Somatostatin, Luteinizing Hormone- Releasing Hormone and Bombesin to Cancers Expressing Their Receptors: A “Smarter” Chemotherapy
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
1167-1180
Author(s):
A. Nagy and A. V. Schally
The Genetic Regulation of ADPRT/PARP-1 in Aging and Cancer Susceptibility
Journal:
Current Pharmacogenomics
Volume:
3
Page:
9-19
Author(s):
Kristin L. Lockett, Isaac V. Snowhite and Jennifer J. Hu
Synthetic Hammerhead Ribozymes as Therapeutic Tools to Control Disease Genes
Journal:
Current Gene Therapy
Volume:
5
Page:
11-24
Author(s):
L. Citti and G. Rainaldi
Therapeutic Potential of Hammerhead Ribozymes in the Treatment of Hyper-Proliferative Diseases
Journal:
Current Pharmaceutical Biotechnology
Volume:
5
Page:
369-386
Author(s):
G. Grassi, P. Dawson, G. Guarnieri, R. Kandolf and M. Grassi
DNA Methylation Leaves Its Mark in Head and Neck Squamous Cell Carcinomas (HNSCC)
Journal:
Current Genomics
Volume:
5
Page:
489-498
Author(s):
L. T. Smith and C. Plass
Polyphenolic Compounds: Interactions with the Gut and Implications for Human Health
Journal:
Current Medicinal Chemistry
Volume:
8
Page:
1245-1255
Author(s):
J. M. Gee and I. T. Johnson